Aratana Therapeutics, Inc. (PETX) Return on Investment ROI from the first quarter of 2019 to first quarter of 2018 and for the year 2019, average high and low, overall ranking from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aratana Therapeutics, Inc.  (PETX)


Aratana Therapeutics,'s ROI from its first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aratana Therapeutics,'s ROI in the first quarter of 2019?
Aratana Therapeutics, Inc. recorded a cumulative net loss of $-13 million during 12 months ending in the first quarter of 2019, resulting in a negative return on investment (ROI) of -12.63%.

Within the Healthcare sector 274 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2018 from 0 to 3512.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Investment Change TTM -10.22 % -6.23 % -9.81 % -13.31 % -11.04 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 97 101 111 102 110
Return On Investment (TTM) -12.63 % -13.91 % -20.54 % -36.72 % -38.01 %
PETX's Overall Ranking # 3512 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -3.06 % 0.28 % -1.72 % -6.03 % 1.24 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -13 -15 -22 -39 -43

PETX Company Profile >> Back to PETX Roi Comparisons >> See Annual PETX Return On Investment



Return On Investment PETX's Ranking
Within: No.
Industry # 93
Sector # 275
Overall # 3512

Return On Investment Statistics
High Average Low
92.48 %
-16.88 %
-66.35 %
(Mar 31 2014)   (Mar 31 2016)







Financial Statements
Aratana Therapeutics,'s I. Quarter Investments $ 97 Millions PETX's Balance sheet
Aratana Therapeutics,'s I. Quarter Income $ -7 Millions Quarterly PETX's Income Statement
PETX's Income by Division See PETX's Income by Division


PETX Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 101 100 116 141 198
Y / Y Investment Growth 1.19 % -14.28 % -17.73 % -28.75 % 101.18 %
Net Income in Millions -15 -48 -34 -84 -39
Y / Y Net Income Growth - - - - -
Annual Return On Investment -14.59 % -47.65 % -28.87 % -59.45 % -19.56 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PETX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PETX's Competitors
Subscribers only: Roi for Aratana Therapeutics,'s Suppliers
Subscribers only: Return On Investment for PETX's Customers

Other Ratios
PETX's Roa PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Statistics
PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:22:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.